CSI Market
Sign In | Register

Lyell Immunopharma Inc (LYEL) Annual Balance Sheets

Annual · GAAP · USD millions
Access LYEL quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Lyell Immunopharma Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent60.18
Marketable Securities, Current SH187.04
Cash & Short-term Investments247.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current13.72
Total Current Assets260.94
Equipment/Property/Plant Net34.77
Long-term investments19.00
Other Assets, Noncurrent44.34
Restricted Cash Noncurrent1.59
Operating Lease Right Of Use Asset18.87
Total Assets340.05
Liabilities
Accounts Payable, Current AC2.89
Accrued Liabilities And Other Liabilities46.52
Other Liabilities, Current0.00
Total Current Liabilities49.41
Total Long-term Debt0.00
Other liabilities, Noncurrent42.44
Asset Acquisition Contingent Consideration Liability Current-
Contract With Customer Liability Current-
Operating Lease Liability Noncurrent41.92
Contract With Customer Liability Noncurrent-
Total Liabilities91.85
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,867.51
Retained Earnings / Accumulated Deficit-1,619.55
Other Equity0.24
Common Stockholder's Equity248.20
Preferred Stockholder's Equity0.00
Total Stockholder's Equity248.20
Liabilities & Stockholder's Equity340.05
4 historic quarters locked

Sign in to unlock the full Lyell Immunopharma Inc balance sheet history.

Sign In Create Free Account

About Lyell Immunopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-017253

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License